"This now will hopefully set the stage for improved ways of differentiating these cells, make these embryonic stem cells turn into other cell types that we can use for other disea ...

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

Human stem cell treatment restores motor function in paralyzed rats Rats paralyzed due to loss of blood flow to the spine returned to near normal ambulatory function six weeks after receiving grafts ...

A clinical trial for spina bifida treatment suggests that a surgical approach relying on stem cells is safe for patients. Its efficacy is still being evaluated.

This graphical abstract illustrates the study design. Notable innovations include the use of a “floating cannula” to deliver stem cells without suspension of respiration, utilizing diffuse tensor ...

Japanese researchers are testing a surprising, minimally invasive way to repair spine fractures. A team at Osaka Metropolitan University found that stem cells from fat tissue can repair breaks similar ...

A phase 1 clinical trial demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic spinal cord injuries. The corresponding study was published in Cell ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...